Seyed Mehrad Razavi
发表
Licofelone, a potent COX/5-LOX inhibitor and a novel option for treatment of neurological disorders.
A. Dehpour,
S. Momtaz,
A. Abdolghaffari,
2021,
Prostaglandins & other lipid mediators.
F. Montecucco,
A. Sahebkar,
S. Momtaz,
2022,
Life.
A. Sahebkar,
G. Barreto,
S. Momtaz,
2022,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
T. Sathyapalan,
A. Sahebkar,
S. Emami,
2022,
Antioxidants.
P. Kesharwani,
T. Sathyapalan,
A. Sahebkar,
2023,
Molecular and cellular biochemistry.
S. Momtaz,
Seyed Mehrad Razavi,
A. Niknejad,
2023,
Revista Brasileira de Farmacognosia.
A. Sahebkar,
S. Momtaz,
A. Butler,
2024,
Diabetes & metabolic syndrome.
A. Sahebkar,
S. Momtaz,
Seyed Mehrad Razavi,
2024,
JOR spine.
A. Sahebkar,
G. Barreto,
S. Momtaz,
2024,
Molecular neurobiology.